US Stock MarketDetailed Quotes

IRWD Ironwood Pharmaceuticals

Watchlist
  • 0.8787
  • +0.1042+13.45%
Close Apr 24 16:00 ET
  • 0.8400
  • -0.0387-4.40%
Post 16:21 ET
142.18MMarket Cap87.87P/E (TTM)

Ironwood Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-43.55%103.55M
-57.54%15.21M
-69.55%9.89M
-4.28%33.47M
-43.89%44.99M
-33.00%183.43M
-54.74%35.83M
-53.02%32.46M
-43.02%34.96M
25.02%80.17M
Net income from continuing operations
100.09%880K
229.28%2.26M
-73.86%3.65M
99.92%-860K
-109.10%-4.16M
-689.24%-1.03B
-103.57%-1.75M
-72.28%13.95M
-3,038.18%-1.09B
17.82%45.71M
Operating gains losses
494.74%75K
--0
--5K
--37K
273.68%33K
89.44%-19K
--0
--0
--0
97.40%-19K
Depreciation and amortization
27.68%2.01M
-5.27%485K
0.00%507K
87.41%506K
79.37%513K
11.07%1.58M
50.59%512K
39.67%507K
-25.00%270K
-19.44%286K
Deferred tax
-6.26%68.09M
31.23%41.1M
-46.12%7.68M
32.44%13.26M
-64.52%6.05M
10.49%72.64M
55.60%31.32M
-10.99%14.26M
-32.77%10.01M
15.94%17.05M
Other non cash items
-99.83%1.9M
-92.57%415K
-40.27%350K
-99.95%550K
46.52%589K
59,128.76%1.1B
1,296.75%5.59M
46.50%586K
211,321.32%1.09B
-25.14%402K
Change In working capital
-93.45%739K
-293.35%-33.61M
-124.04%-10.63M
-23.78%11.41M
249.58%33.58M
299.96%11.28M
-500.23%-8.55M
3.54%-4.75M
1,105.88%14.97M
120.10%9.61M
-Change in receivables
5,012.12%47.24M
-24.19%-5.68M
-225.68%-18.1M
529.13%13.91M
299.41%57.11M
-88.44%924K
-588.47%-4.58M
61.25%-5.56M
-207.60%-3.24M
-22.22%14.3M
-Change in prepaid assets
-97.89%89K
-62.83%2.27M
-91.86%357K
102.73%71K
28.95%-2.61M
30.89%4.22M
270.66%6.1M
54.36%4.39M
-97.34%-2.6M
-7,022.64%-3.67M
-Change in payables and accrued expense
-635.86%-34.86M
-21.96%-8.48M
198.71%2.76M
-139.93%-7.16M
-1,208.93%-21.98M
134.69%6.51M
-186.92%-6.95M
-169.96%-2.79M
751.49%17.93M
90.44%-1.68M
-Change in other current assets
-37.03%704K
28.15%519K
54.48%431K
-1,227.59%-654K
8.51%408K
-24.46%1.12M
13.13%405K
-18.90%279K
-85.89%58K
2.45%376K
-Change in other current liabilities
-735.48%-12.43M
-531.35%-22.24M
468.49%3.92M
85.98%5.24M
131.54%646K
-116.76%-1.49M
-317.81%-3.52M
-147.46%-1.06M
49.34%2.82M
-91.09%279K
Cash from discontinued investing activities
Operating cash flow
-43.55%103.55M
-57.54%15.21M
-69.55%9.89M
-4.28%33.47M
-43.89%44.99M
-33.00%183.43M
-54.74%35.83M
-53.02%32.46M
-43.02%34.96M
25.02%80.17M
Investing cash flow
Cash flow from continuing investing activities
99.99%-142K
0
99.93%-16K
99.99%-58K
-423.08%-68K
-754,545.59%-1.03B
-15,611.11%-4.19M
-34,180.30%-22.63M
-1,135,686.36%-999.49M
-44.44%-13K
Net PPE purchase and sale
47.99%-142K
--0
67.35%-16K
---58K
-423.08%-68K
-100.74%-273K
-881.48%-211K
25.76%-49K
--0
-44.44%-13K
Net business purchase and sale
--0
--0
--0
----
----
---1.03B
---3.98M
---22.58M
----
----
Cash from discontinued investing activities
Investing cash flow
99.99%-142K
--0
99.93%-16K
99.99%-58K
-423.08%-68K
-754,545.59%-1.03B
-15,611.11%-4.19M
-34,180.30%-22.63M
-1,135,686.36%-999.49M
-44.44%-13K
Financing cash flow
Cash flow from continuing financing activities
-138.60%-106.97M
70.75%-14.89M
63.79%-27.16M
-112.37%-49.37M
-490.73%-15.56M
216.67%277.16M
-1,914.11%-50.9M
-9,508.78%-74.99M
365.55%399.07M
104.38%3.98M
Net issuance payments of debt
-138.33%-115M
40.00%-15M
66.67%-25M
-112.50%-50M
---25M
348.55%300M
---25M
---75M
--400M
--0
Net common stock issuance
--0
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
73.24%11.01M
-79.66%203K
--0
-45.17%749K
152.73%10.06M
-33.36%6.36M
-64.43%998K
-98.49%12K
-68.34%1.37M
145.44%3.98M
Net other financing activities
89.78%-2.98M
99.67%-90K
---2.16M
---121K
---616K
---29.2M
---26.9M
--0
----
----
Cash from discontinued financing activities
Financing cash flow
-138.60%-106.97M
70.75%-14.89M
63.79%-27.16M
-112.37%-49.37M
-490.73%-15.56M
216.67%277.16M
-1,914.11%-50.9M
-9,508.78%-74.99M
365.55%399.07M
104.38%3.98M
Net cash flow
Beginning cash position
-85.99%92.15M
-20.86%88.21M
-40.25%105.52M
-83.62%121.54M
-85.99%92.15M
5.80%657.94M
-80.65%111.46M
-65.10%176.62M
24.70%742.08M
5.80%657.94M
Current changes in cash
99.37%-3.56M
101.70%327K
73.47%-17.29M
97.18%-15.97M
-65.10%29.36M
-1,668.25%-565.73M
-123.48%-19.26M
-193.31%-65.15M
-535.30%-565.46M
414.44%84.14M
Effect of exchange rate changes
39.62%-32K
142.00%21K
-766.67%-26K
---51K
--24K
---53K
---50K
---3K
--0
--0
End cash Position
-3.90%88.56M
-3.90%88.56M
-20.86%88.21M
-40.25%105.52M
-83.62%121.54M
-85.99%92.15M
-85.99%92.15M
-80.65%111.46M
-65.10%176.62M
24.70%742.08M
Free cash flow
-43.54%103.41M
-57.29%15.21M
-69.55%9.87M
-4.45%33.41M
-43.96%44.92M
-33.06%183.15M
-55.03%35.62M
-53.05%32.41M
-42.94%34.96M
25.02%80.16M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -43.55%103.55M-57.54%15.21M-69.55%9.89M-4.28%33.47M-43.89%44.99M-33.00%183.43M-54.74%35.83M-53.02%32.46M-43.02%34.96M25.02%80.17M
Net income from continuing operations 100.09%880K229.28%2.26M-73.86%3.65M99.92%-860K-109.10%-4.16M-689.24%-1.03B-103.57%-1.75M-72.28%13.95M-3,038.18%-1.09B17.82%45.71M
Operating gains losses 494.74%75K--0--5K--37K273.68%33K89.44%-19K--0--0--097.40%-19K
Depreciation and amortization 27.68%2.01M-5.27%485K0.00%507K87.41%506K79.37%513K11.07%1.58M50.59%512K39.67%507K-25.00%270K-19.44%286K
Deferred tax -6.26%68.09M31.23%41.1M-46.12%7.68M32.44%13.26M-64.52%6.05M10.49%72.64M55.60%31.32M-10.99%14.26M-32.77%10.01M15.94%17.05M
Other non cash items -99.83%1.9M-92.57%415K-40.27%350K-99.95%550K46.52%589K59,128.76%1.1B1,296.75%5.59M46.50%586K211,321.32%1.09B-25.14%402K
Change In working capital -93.45%739K-293.35%-33.61M-124.04%-10.63M-23.78%11.41M249.58%33.58M299.96%11.28M-500.23%-8.55M3.54%-4.75M1,105.88%14.97M120.10%9.61M
-Change in receivables 5,012.12%47.24M-24.19%-5.68M-225.68%-18.1M529.13%13.91M299.41%57.11M-88.44%924K-588.47%-4.58M61.25%-5.56M-207.60%-3.24M-22.22%14.3M
-Change in prepaid assets -97.89%89K-62.83%2.27M-91.86%357K102.73%71K28.95%-2.61M30.89%4.22M270.66%6.1M54.36%4.39M-97.34%-2.6M-7,022.64%-3.67M
-Change in payables and accrued expense -635.86%-34.86M-21.96%-8.48M198.71%2.76M-139.93%-7.16M-1,208.93%-21.98M134.69%6.51M-186.92%-6.95M-169.96%-2.79M751.49%17.93M90.44%-1.68M
-Change in other current assets -37.03%704K28.15%519K54.48%431K-1,227.59%-654K8.51%408K-24.46%1.12M13.13%405K-18.90%279K-85.89%58K2.45%376K
-Change in other current liabilities -735.48%-12.43M-531.35%-22.24M468.49%3.92M85.98%5.24M131.54%646K-116.76%-1.49M-317.81%-3.52M-147.46%-1.06M49.34%2.82M-91.09%279K
Cash from discontinued investing activities
Operating cash flow -43.55%103.55M-57.54%15.21M-69.55%9.89M-4.28%33.47M-43.89%44.99M-33.00%183.43M-54.74%35.83M-53.02%32.46M-43.02%34.96M25.02%80.17M
Investing cash flow
Cash flow from continuing investing activities 99.99%-142K099.93%-16K99.99%-58K-423.08%-68K-754,545.59%-1.03B-15,611.11%-4.19M-34,180.30%-22.63M-1,135,686.36%-999.49M-44.44%-13K
Net PPE purchase and sale 47.99%-142K--067.35%-16K---58K-423.08%-68K-100.74%-273K-881.48%-211K25.76%-49K--0-44.44%-13K
Net business purchase and sale --0--0--0-----------1.03B---3.98M---22.58M--------
Cash from discontinued investing activities
Investing cash flow 99.99%-142K--099.93%-16K99.99%-58K-423.08%-68K-754,545.59%-1.03B-15,611.11%-4.19M-34,180.30%-22.63M-1,135,686.36%-999.49M-44.44%-13K
Financing cash flow
Cash flow from continuing financing activities -138.60%-106.97M70.75%-14.89M63.79%-27.16M-112.37%-49.37M-490.73%-15.56M216.67%277.16M-1,914.11%-50.9M-9,508.78%-74.99M365.55%399.07M104.38%3.98M
Net issuance payments of debt -138.33%-115M40.00%-15M66.67%-25M-112.50%-50M---25M348.55%300M---25M---75M--400M--0
Net common stock issuance --0------------------0----------------
Proceeds from stock option exercised by employees 73.24%11.01M-79.66%203K--0-45.17%749K152.73%10.06M-33.36%6.36M-64.43%998K-98.49%12K-68.34%1.37M145.44%3.98M
Net other financing activities 89.78%-2.98M99.67%-90K---2.16M---121K---616K---29.2M---26.9M--0--------
Cash from discontinued financing activities
Financing cash flow -138.60%-106.97M70.75%-14.89M63.79%-27.16M-112.37%-49.37M-490.73%-15.56M216.67%277.16M-1,914.11%-50.9M-9,508.78%-74.99M365.55%399.07M104.38%3.98M
Net cash flow
Beginning cash position -85.99%92.15M-20.86%88.21M-40.25%105.52M-83.62%121.54M-85.99%92.15M5.80%657.94M-80.65%111.46M-65.10%176.62M24.70%742.08M5.80%657.94M
Current changes in cash 99.37%-3.56M101.70%327K73.47%-17.29M97.18%-15.97M-65.10%29.36M-1,668.25%-565.73M-123.48%-19.26M-193.31%-65.15M-535.30%-565.46M414.44%84.14M
Effect of exchange rate changes 39.62%-32K142.00%21K-766.67%-26K---51K--24K---53K---50K---3K--0--0
End cash Position -3.90%88.56M-3.90%88.56M-20.86%88.21M-40.25%105.52M-83.62%121.54M-85.99%92.15M-85.99%92.15M-80.65%111.46M-65.10%176.62M24.70%742.08M
Free cash flow -43.54%103.41M-57.29%15.21M-69.55%9.87M-4.45%33.41M-43.96%44.92M-33.06%183.15M-55.03%35.62M-53.05%32.41M-42.94%34.96M25.02%80.16M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Sample Name
Sample Code
 +78.53%
Sample Name
Sample Code
 +24.06%
Sample Name
Sample Code
 +20.03%
4
Kingchem
301509
+20.02%
5
Hunan Er-kang Pharmaceutical
300267
+20.00%
Unlock Now

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 188.150
Sample Name
Sample Code
 264.700
Sample Name
Sample Code
 147.210
4
Oracle
ORCL
137.510
5
Advanced Micro Devices
AMD
94.470
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 10.060
Sample Name
Sample Code
 0.4200
Sample Name
Sample Code
 3.040
4
Mawson Infrastructure
MIGI
0.4618
5
BIT Mining
BTCM
1.910
Unlock Now

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -